|
1
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ota K, Quint P, Weivoda MM, Ruan M,
Pederson L, Westendorf JJ, Khosla S and Oursler MJ: Transforming
growth factor beta 1 induces CXCL16 and leukemia inhibitory factor
expression in osteoclasts to modulate migration of osteoblast
progenitors. Bone. 57:68–75. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyce BF, Zuscik MJ and Xing L: Biology of
bone and cartilageGenetics of bone biology and skeletal disease.
Thakker RV, Eisman J, Igarashi T and Whyte MP: Elsevier; London,
UK: pp. 3–24. 2012
|
|
4
|
Boyce BF: Advances in the regulation of
osteoclasts and osteoclast functions. J Dent Res. 92:860–867. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kikuta J, Iwai K, Saeki Y and Ishii M:
S1P-targeted therapy for elderly rheumatoid arthritis patients with
osteoporosis. Rheumatol Int. 31:967–969. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishii M and Kikuta J:
Sphingosine-1-phosphate signaling controlling osteoclasts and bone
homeostasis. Biochim Biophys Acta. 1831:223–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu X, Huang Y, Collin-Osdoby P and Osdoby
P: Stromal cell-derived factor-1 (SDF-1) recruits osteoclast
precursors by inducing chemotaxis, matrix metalloproteinase-9
(MMP-9) activity, and collagen transmigration. J Bone Miner Res.
18:1404–1418. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright LM, Maloney W, Yu X, Kindle L,
Collin-Osdoby P and Osdoby P: Stromal cell-derived factor-1 binding
to its chemokine receptor CXCR4 on precursor cells promotes the
chemotactic recruitment, development and survival of human
osteoclasts. Bone. 36:840–853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rahimi RA and Leof EB: TGF-beta Signaling:
A tale of two responses. J Cell Biochem. 102:593–608. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janssens K, ten Dijke P, Janssens S and
Van Hul W: Transforming growth factor-beta1 to the bone. Endocr
Rev. 26:743–774. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang SY and Alliston T: Regulation of
postnatal bone homeostasis by TGFβ. Bonekey Rep. 9:2552013.
|
|
12
|
Ikushima H and Miyazono K: TGF-b signal
transduction spreading to a wider field: A broad variety of
mechanisms for context-dependent effects of TGF-b. Cell Tissue Res.
347:37–49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koseki T, Gao Y, Okahashi N, Murase Y,
Tsujisawa T, Sato T, Yamato K and Nishirara T: Role of TGF-beta
family in osteoclastogenesis induced by RANKL. Cell Signal.
14:31–36. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shui C, Riggs BL and Khosla S: The
immunosuppressant rapamycin, alone or with transforming growth
factor-beta, enhances osteoclast differentiation of RAW264.7
monocyte-macrophage cells in the presence of RANK-ligand. Calcif
Tissue Int. 71:437–446. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chin SL, Johnson SA, Quinn J,
Mirosavljevic D, Price JT, Dudley AC and Thomas DM: A role for
alphaV integrinsubunitin TGF-beta-stimulated osteoclastogenesis.
Biochem Biophys Res Commun. 307:1051–1058. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fox SW, Evans KE and Lovibond AC:
Transforming growth factor-beta enables NFATc1 expression during
osteoclastogenesis. Biochem Biophys Res Commun. 366:123–128. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yasui T, Kadono Y, Nakamura M, Oshima Y,
Matsumoto T, Masuda H, Hirose J, Omata Y, Yasuda H, Imamura T, et
al: Regulation of RANKL-induced osteoclastogenesis by TGF-b through
molecular interaction between Smad3 and Traf6. J Bone Miner Res.
26:1447–1456. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JS, Kim JG, Moon MY, Jeon CY, Won HY,
Kim HJ, Jeon YJ, Seo JY, Kim JI, Kim J, et al: Transforming growth
factor-1 regulates macrophage migration via RhoA. Blood.
108:1821–1829. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi N, Yamana H, Yoshiki S, Roodman
GD, Mundy GR, Jones SJ, Boyde A and Suda T: Osteoclast-like cell
formation and its regulation by osteotropic hormones in mouse bone
marrow cultures. Endocrinology. 122:1373–1382. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashitani S, Urade M, Nishimura N, Maeda
T, Takaoka K, Noguchi K and Sakurai K: Apoptosis induction and
enhancement of cytotoxicity of anticancer drugs by celecoxib, a
selective cyclooxygenase-2 inhibitor, in human head and neck
carcinoma cell lines. Int J Oncol. 23:665–672. 2003.PubMed/NCBI
|
|
21
|
Hiromoto T, Noguchi K, Yamamura M, Zushi
Y, Segawa E, Takaoka K, Moridera K, Kishimoto H and Urade M:
Up-regulation of neurophil gelatinase-associated lipocalin in oral
squamous cell carcinoma: Relation to cell differentiation. Oncol
Rep. 26:1415–1421. 2013.
|
|
22
|
Baksh D, Song L and Tuan RS: Adult
mesenchymal stem cells: Characterization, differentiation, and
application in cell and gene therapy. J Cell Mol Med. 8:301–316.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simonet WS, Lacey DL, Dunstan CR, Kelley
M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et
al: Osteoprotegerin: A novel secreted protein involved in the
regulation of bone density. Cell. 89:309–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ridley AJ: Rho GTPases and cell migration.
J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI
|
|
25
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor-beta in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massague J: TGFbeta in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian M, Neil JR and Schiemann WP:
Transforming growth factor-β and the hallmarks of cancer. Cell
Signal. 23:951–962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morrison CD, Parvani JG and Schiemann WP:
The relevance of the TGF-β paradox to EMT-MET programs. Cancer
Lett. 341:30–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park JH, Lee NK and Lee SY: Current
understanding of RANK signaling in osteoclast differentiation and
maturation. Mol Cells. 40:706–713. 2017.PubMed/NCBI
|
|
31
|
Houde N, Chamoux E, Bisson M and Roux S:
Transforming growth factor-beta1 (TGF-beta1) induces human
osteoclast apoptosis by up-regulating Bim. J Biol Chem.
284:23397–23404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cox EA, Sastry SK and Huttenlocher A:
Integrin-mediated adhesion regulates cell polarity and membrane
protrusion through the Rho family of GTPases. Mol Biol Cell.
12:265–277. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mitchison TJ and Cramer LP: Actin-based
cell motility and cell locomotion. Cell. 84:371–379. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Allen WE, Zicha D, Ridley AJ and Jones GE:
A role for Cdc42 in macrophage chemotaxis. J Cell Biol.
141:1147–1157. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Murphy-Ulirich JE: The de-adhesive
activity of matricellular proteins: Is intermediate cell adhesion
an adaptive state? J Clin Invest. 107:785–790. 2001. View Article : Google Scholar : PubMed/NCBI
|
